BioMarin Pharmaceutical
BMRN
#1754
Rank
โ‚ฌ10.41 B
Marketcap
54,24ย โ‚ฌ
Share price
1.61%
Change (1 day)
-17.67%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: โ‚ฌ10.41 Billion

As of February 2026 BioMarin Pharmaceutical has a market cap of โ‚ฌ10.41 Billion. This makes BioMarin Pharmaceutical the world's 1754th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ10.41 B6.28%
2025โ‚ฌ9.80 B-19.97%
2024โ‚ฌ12.25 B-25.44%
2023โ‚ฌ16.42 B-8.37%
2022โ‚ฌ17.93 B25.19%
2021โ‚ฌ14.32 B10.67%
2020โ‚ฌ12.94 B-4.65%
2019โ‚ฌ13.57 B2.3%
2018โ‚ฌ13.26 B1.66%
2017โ‚ฌ13.05 B-3.64%
2016โ‚ฌ13.54 B-12.48%
2015โ‚ฌ15.47 B39.65%
2014โ‚ฌ11.08 B51.64%
2013โ‚ฌ7.30 B56.18%
2012โ‚ฌ4.67 B54.76%
2011โ‚ฌ3.02 B34.99%
2010โ‚ฌ2.23 B68.98%
2009โ‚ฌ1.32 B4.29%
2008โ‚ฌ1.27 B-46.02%
2007โ‚ฌ2.35 B106.65%
2006โ‚ฌ1.13 B68.51%
2005โ‚ฌ0.67 B122.53%
2004โ‚ฌ0.30 B-23.16%
2003โ‚ฌ0.39 B9.02%
2002โ‚ฌ0.36 B-54.52%
2001โ‚ฌ0.79 B110.03%
2000โ‚ฌ0.37 B-6.65%
1999โ‚ฌ0.40 B

End of Day market cap according to different sources

On Feb 23rd, 2026 the market cap of BioMarin Pharmaceutical was reported to be:

โ‚ฌ10.25 Billion
by Nasdaq info icon info icon
โ‚ฌ10.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚ฌ97.80 B 838.65%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
โ‚ฌ1.86 B-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ0.12 B-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.67 B-93.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ3.81 B-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ2.52 B-75.77%๐Ÿ‡บ๐Ÿ‡ธ USA